Gerard V. Walls
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genetic background influences tumour development in heterozygous Men1 knockout mice.
Journal: Endocrine connections
Published: April 17, 2020
miR-15a/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs.
Journal: The Journal of endocrinology
Published: September 25, 2018
Bilateral adrenalectomy: a review of 10 years' experience.
Journal: Annals of the Royal College of Surgeons of England
Published: August 24, 2016
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Journal: Oncogene
Published: August 18, 2016
Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.
Journal: Endocrinology
Published: March 19, 2016
Multiple endocrine neoplasia (MEN) syndromes.
Journal: Seminars in pediatric surgery
Published: June 17, 2014
Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Journal: Endocrinology
Published: October 02, 2012
MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.
Journal: Cancer research
Published: August 24, 2012
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
Journal: The Journal of clinical endocrinology and metabolism
Published: June 23, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026